Navigation Links
Study: No link between depression, nasal obstruction

DETROIT While mood disorders like depression or anxiety tend to negatively affect treatment for allergies and chronic rhinosinusitis, the same cannot be said for patients with nasal obstructions such as deviated septum, according to researchers at Henry Ford Hospital.

The new study shows mood disorders are not linked to either nasal obstructive symptoms or the failure of nasal obstruction surgery.

Results also suggest that those patients with nasal obstruction caused by septal deviation a blockage of the nasal airway caused by a portion of cartilage or bony septum who do not have signs and symptoms of allergic rhinitis would not benefit from depression screening if nasal treatment is unsuccessful.

"Although the literature supports more negative outcomes of allergic rhinitis and chronic rhinosinusitis patients with mood disorders, our data does not show a similar relationship for septal deviation," says study author Lamont R. Jones, M.D., vice chair, Department of Otolaryngology-Head and Neck Surgery at Henry Ford.

"It's unclear why depression would exacerbate symptoms after certain nasal procedures, but not others; although it's very likely that the difference could be due to the inflammatory nature of rhinosinusitis and seasonal allergies."

The study will be presented this week at the Combined Otolaryngological Spring Meetings in San Diego.

Nasal obstruction is a common complaint among patients in otolaryngology (ear, nose and throat) clinics. It is often caused by inflammation from inhalant allergies, mucosal edema from chronic rhinosinusitis, and mechanical obstruction from a deflected septum.

Treatment ranges from nasal saline irrigations, topical corticosteroid sprays, allergy control and surgery. Yet some patients lack long-lasting benefit from treatment. According to some research reports, many of these difficult-to-treat nasal patients may also have a mood disorder.

While the effect of depression on chronic rhinosinusitis has been widely reported with patients requiring longer follow-up and having less satisfaction with nasal and sinus surgery outcome little is known about the effect of mood disorders on nasal obstruction symptoms and surgical outcomes.

To determine if there might be a possible link between surgical failure of non-allergic nasal obstruction and a co-morbid mood disorder, Dr. Jones and Brandon Musgrave, M.D., conducted a retrospective review of 437 patients who had surgery between 2005 and 2010 for septal deviation at Henry Ford.

Among the patients, 398 (91 percent) had a successful surgical outcome for nasal obstruction, while 39 (nearly 9 percent) did not.

Within the surgical success group, 31 percent had a co-morbid mood disorder, compared to 36 percent of the surgical failures. The researchers note, however, that this difference in mood disorder prevalence was not statistically significant.

According to study findings, the only significant result was that successfully treated nasal obstruction patients had shorter post-operative follow up.

That finding, notes Dr. Jones, is to be expected as patients with persistent nasal symptoms are more likely to continue following up with their surgeon for potential relief.


Contact: Krista Hopson
Henry Ford Health System

Related medicine news :

1. Study: Choice between stroke-prevention procedures influenced by patient age
2. UNC study: Obese 3-year-olds show early warning signs for future heart disease
3. New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
4. Henry Ford Hospital study: Shoulder function not fully restored after surgery
5. Study: Federal funds support health depts., but leadership is key
6. Study: Kidney disease a big risk for younger, low-income minorities
7. Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery
8. Study: Low Levels of Vitamin D Linked to Higher Rates of Asthma in African American Kids
9. Study: Child health may suffer in strong economy
10. Study: Social influence playing role in surging autism diagnoses
11. Children's Rights Group Agrees with New Study: Infant Circumcision Causes 100 Deaths Each Year in US
Post Your Comments:
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
(Date:11/26/2015)... San Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... accomplishment! On November 19, 2015, our surgeons performed their 6,000th free flap breast ... Ledoux , “We wake up every day excited to rebuild lives and it’s an ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film ... trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 ... with any font, giving users limitless opportunities to stylize and create designs quickly ...
(Date:11/26/2015)... ... ... Inc., developer and distributor of the world-class Asterisk based contact center software Q-Suite, announces ... new Q-Suite 6 platform is based on the latest Java Enterprise standards. By conforming ... of software for many key components of the suite. Much of the suite runs ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part ... For Empowerment ™ attracts volunteers together who want to combine talents and resources ... key stakeholders in the process. The non-profit launched its first major fundraiser on ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Monitoring (TDM) Market: Supplier Shares, Country ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "Radioimmunoassay Market by ... (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), ... Global Forecast to 2020" report to ... has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
Breaking Medicine Technology: